Australia's most trusted
source of pharma news
Thursday, 11 September 2025
Posted 8 September 2025 AM
Export only drugs dominated entries onto the ARTG last week, with cannabis medicines taking the lead.
The only scheduled medicine approved by the TGA last week was a tablet blister pack presentation of Noumed Pharmaceuticals’ over the counter nonsteroidal anti-inflammatory drug Harmonex, joining the existing film coated tablet blister pack presentation of the medicine.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.